Vertex Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	5,493	5,085	4,570	10,369	10,504	6,795
Short-Term Investments	1,754	1,523	1,546	849.2	274.5	729.9
Cash & Short-Term Investments	7,247	6,608	6,116	11,218	10,779	7,525
Cash Growth	16.86%	8.05%	-45.48%	4.08%	43.24%	13.00%
Accounts Receivable	1,996	2,053	1,609	1,563	1,442	1,137
Inventory	1,767	1,687	1,205	738.8	460.6	353.1
Other Current Assets	720.8	853.3	665.7	623.7	553.5	545.8
Total Current Assets	11,730	11,201	9,596	14,144	13,235	9,561
Net Property, Plant & Equipment	3,294	3,083	2,585	1,453	1,456	1,424
Other Intangible Assets	418.5	424.2	825.9	839.9	603.6	400
Goodwill	1,088	1,088	1,088	1,088	1,088	1,002
Long-Term Investments	5,750	5,712	5,108	2,498	112.2	-
Other Long-Term Assets	4,204	4,135	3,330	2,707	1,657	1,045
Total Assets	26,484	25,643	22,533	22,730	18,151	13,433
Accounts Payable	489.3	461.7	413	364.9	303.9	195
Accrued Expenses	2,984	2,971	2,789	2,655	2,127	1,679
Other Current Liabilities	407.1	428.3	363	527.2	311.5	268.4
Total Current Liabilities	3,881	3,861	3,565	3,547	2,742	2,142
Long-Term Leases	1,987	1,847	1,544	724.7	810.3	887.2
Other Long-Term Liabilities	1,255	1,270	1,015	877.7	685.8	303.3
Total Long-Term Liabilities	3,242	3,116	2,559	1,602	1,496	1,191
Total Liabilities	7,123	6,977	6,124	5,150	4,238	3,333
Preferred Stock	-	-	-	2.6	2.6	-
Common Stock	2.5	2.5	2.6	2.6	-	2.5
Additional Paid-in Capital	4,743	5,119	6,672	7,450	7,387	6,881
Accumulated Other Comprehensive Income	24.8	-15.9	127.8	-14.3	0.8	15.9
Retained Earnings	14,591	13,560	9,607	10,142	6,523	3,201
Total Common Shareholders' Equity	19,362	18,666	16,410	17,583	13,913	10,100
Shareholders' Equity	19,362	18,666	16,410	17,580	13,913	10,100
Total Liabilities & Equity	26,484	25,643	22,533	22,730	18,151	13,433
Total Debt	1,987	1,847	1,544	724.7	810.3	887.2
Net Cash (Debt)	5,260	4,762	4,572	10,494	9,968	6,638
Net Cash Growth	10.47%	4.16%	-56.44%	5.27%	50.18%	15.05%
Net Cash Per Share	20.45	18.46	17.73	40.28	38.47	25.54
Book Value	19,362	18,666	16,410	17,583	13,913	10,100
Book Value Per Share	75.27	72.35	63.63	67.50	53.70	38.86
Tangible Book Value	17,855	17,154	14,496	15,655	12,221	8,698
Tangible Book Value Per Share	69.42	66.49	56.21	60.10	47.17	33.47

SEC Filings: 10-K · 10-Q